EP 3399970 A1 20181114 - COMPOSITION THERAPY WITH AN IRON COMPOUND AND A CITRATE COMPOUND
Title (en)
COMPOSITION THERAPY WITH AN IRON COMPOUND AND A CITRATE COMPOUND
Title (de)
KOMBINATIONSTHERAPIE MIT EINER EISENVERBINDUNG UND EINER CITRATVERBINDUNG
Title (fr)
POLYTHÉRAPIE COMPRENANT COMPOSÉ DE FER ET COMPOSÉ DE CITRATE
Publication
Application
Priority
- US 201662275487 P 20160106
- US 201662432564 P 20161209
- US 2017012300 W 20170105
Abstract (en)
[origin: WO2017120311A1] Combination therapy comprising an iron compound, preferably soluble ferric pyrophosphate (SFP), in combination with a citrate compound is disclosed. Methods of using the combination therapy in the treatment of iron deficiency, with or without anemia, including iron-refractory iron deficiency anemia and other iron-sequestration syndromes, and pharmaceutical compositions and kits comprising SFP or another iron compound and a citrate compound are also disclosed.
IPC 8 full level
A61K 9/12 (2006.01); A61K 31/194 (2006.01); A61K 33/26 (2006.01); A61P 7/06 (2006.01)
CPC (source: EP)
A61K 9/0095 (2013.01); A61K 31/194 (2013.01); A61K 33/26 (2013.01); A61K 47/02 (2013.01); A61P 7/06 (2017.12); A61K 9/0019 (2013.01)
Citation (search report)
See references of WO 2017120311A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017120311 A1 20170713; CA 3010771 A1 20170713; CN 108883085 A 20181123; EP 3399970 A1 20181114; JP 2019501184 A 20190117
DOCDB simple family (application)
US 2017012300 W 20170105; CA 3010771 A 20170105; CN 201780015440 A 20170105; EP 17703245 A 20170105; JP 2018535110 A 20170105